SCHEMBL2723732

SCHEMBL2723732

Cc1ccc(C(NC2CCN(C)CC2)c2nc3ccccc3s2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.42
ALDH1A1 P00352 3/20 0.42
ALOX12 P18054 3/20 0.42
LMNA P02545 3/20 0.42
UBE2M P61081 3/20 0.42
DCUN1D1 Q96GG9 3/20 0.42
CASR P41180 1/20 0.40
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
GAA P10253 2/20 0.39
TSHR P16473 2/20 0.38
MAPK1 P28482 1/20 0.38
HPGD P15428 1/20 0.38
USP2 O75604 1/20 0.38
TP53 P04637 1/20 0.38
ALOX15 P16050 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2720537 0.92 HPGD (0.46) NPC1RAB9AKMT2AGAATSHR
SCHEMBL899905 0.88 UBE2M (0.42) SMN1; SMN2ALDH1A1ALOX12LMNAUBE2M
SCHEMBL2720396 0.86 ALDH1A1 (0.38) SMN1; SMN2ALDH1A1ALOX12LMNAUBE2M
SCHEMBL2720951 0.86 CASR (0.39) ALDH1A1ALOX12UBE2MDCUN1D1CASR
SCHEMBL2720741 0.85 HPGD (0.39) ALDH1A1ALOX12LMNAMEN1NPC1
SCHEMBL899811 0.83 KMT2A (0.43) ALDH1A1ALOX12LMNAUBE2MDCUN1D1
SCHEMBL2722543 0.83 HPGD (0.38) ALDH1A1ALOX12LMNAUBE2MDCUN1D1
SCHEMBL2719898 0.83 HPGD (0.40) KMT2AMAPK1HPGDLOXL2
SCHEMBL17491713 0.81 HRH3 (0.43) ALDH1A1ALOX12LMNAUBE2MDCUN1D1
SCHEMBL2723425 0.81 HPGD (0.39) SMN1; SMN2ALDH1A1ALOX12LMNAUBE2M

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3378476-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS Sensorion (FR) 2018-09-26 EP disclosed
US-9688989-B2 H4 receptor inhibitors for treating tinnitus SENSORION (FR) 2017-06-27 US disclosed
EP-2621916-B1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET SOC CIV (FR) 2016-02-10 EP disclosed
US-20150176010-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS SENSORION (FR) 2015-06-25 US disclosed
EP-2858647-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS Sensorion (FR) 2015-04-15 EP disclosed
WO-2013182711-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS SENSORION (FR) 2013-12-12 WO disclosed
EP-2447263-A1 Benzazole derivatives as histamine H4 receptor ligands BIOPROJET (FR) 2012-05-02 EP disclosed